Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by D A Boudreau
Ubiquitin-Like (UBX)-domain-containing Protein, UBXN2A, Promotes Cell Death by Interfering With the P53-Mortalin Interactions in Colon Cancer Cells
Cell Death and Disease
Molecular Neuroscience
Immunology
Cell Biology
Cancer Research
Cellular
Medicine
Related publications
Protein Domain-Domain Interactions and Requirements for the Negative Regulation ofArabidopsisCDC48/p97 by the Plant Ubiquitin Regulatory X (UBX) Domain-Containing Protein, PUX1
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Septin4 Promotes Cell Death in Human Colon Cancer Cells by Interacting With BAX
International Journal of Biological Sciences
Applied Microbiology
Evolution
Ecology
Developmental Biology
Cell Biology
Molecular Biology
Systematics
Behavior
Biotechnology
Death Domain-Associated Protein Promotes Colon Cancer Metastasis Through Direct Interaction With ZEB1
Journal of Cancer
Oncology
Ubiquitin Ligase A20 Regulates P53 Protein in Human Colon Epithelial Cells
Journal of Biomedical Science
Cell Biology
Pharmacology
Biochemistry
Endocrinology
Clinical Biochemistry
Molecular Biology
Medicine
Metabolism
Diabetes
Ubiquitin-Like Protein FAT10 Promotes Bladder Cancer Progression by Stabilizing Survivin
Oncotarget
Oncology
Ubiquitin-Associated Domain-Containing Ubiquitin Regulatory X (UBX) Protein UBXN1 Is a Negative Regulator of Nuclear Factor κB (NF-κB) Signaling
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Apoptosis Caused by P53-Induced Protein With Death Domain (PIDD) Depends on the Death Adapter Protein RAIDD
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Kaposi's Sarcoma-Associated Herpesvirus K7 Protein Targets a Ubiquitin-Like/Ubiquitin-Associated Domain-Containing Protein to Promote Protein Degradation
Molecular and Cellular Biology
Cell Biology
Molecular Biology
ErbB2 Inhibition by Lapatinib Promotes Degradation of Mutant P53 Protein in Cancer Cells
Oncotarget
Oncology
